Fischer Medical Ventures Closes Trading Window from Oct 1, 2026

Fischer Medical Ventures Ltd has announced the closure of its trading window for Promoters, Directors, and Designated Persons. This closure will be effective from October 1, 2026, and will continue until 48 hours after the declaration of the Un-Audited Financial Results for the quarter ended September 30, 2026. The company will separately inform the stock exchanges about the board meeting scheduled to approve these financial results. Designated persons and their immediate relatives are prohibited from trading in the company's securities during this period.